Literature DB >> 9060903

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

B F Stewart1, D Siscovick, B K Lind, J M Gardin, J S Gottdiener, V E Smith, D W Kitzman, C M Otto.   

Abstract

OBJECTIVES: The aim of this study was to determine the prevalence of aortic sclerosis and stenosis in the elderly and to identify clinical factors associated with degenerative aortic valve disease.
BACKGROUND: Several lines of evidence suggest that degenerative aortic valve disease is not an inevitable consequence of aging and may be associated with specific clinical factors.
METHODS: In 5,201 subjects > or = 65 years of age enrolled in the Cardiovascular Health Study, the relation between aortic sclerosis or stenosis identified on echocardiography and clinical risk factors for atherosclerosis was evaluated by using stepwise logistic regression analysis.
RESULTS: Aortic valve sclerosis was present in 26% and aortic valve stenosis in 2% of the entire study cohort; in subjects > or = 75 years of age, sclerosis was present in 37% and stenosis in 2.6%. Independent clinical factors associated with degenerative aortic valve disease included age (twofold increased risk for each 10-year increase in age), male gender (twofold excess risk), present smoking (35% increase in risk) and a history of hypertension (20% increase in risk). Other significant factors included height and high lipoprotein(a) and low density lipoprotein cholesterol levels.
CONCLUSIONS: Clinical factors associated with aortic sclerosis and stenosis can be identified and are similar to risk factors for atherosclerosis.

Entities:  

Mesh:

Year:  1997        PMID: 9060903     DOI: 10.1016/s0735-1097(96)00563-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  440 in total

Review 1.  Worldwide perspective of valve disease.

Authors:  J Soler-Soler; E Galve
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 2.  Clinical significance of the bicuspid aortic valve.

Authors:  C Ward
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 3.  Timing of aortic valve surgery.

Authors:  C M Otto
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

Review 4.  Interface between valve disease and ischaemic heart disease.

Authors:  B Iung
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

5.  The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis.

Authors:  J R Ortlepp; R Hoffmann; F Ohme; J Lauscher; F Bleckmann; P Hanrath
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 6.  Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Authors:  Nalini M Rajamannan; Bernard Gersh; Robert O Bonow
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

7.  Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

Authors:  J R Ortlepp; F Schmitz; T Bozoglu; P Hanrath; R Hoffmann
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

8.  T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves.

Authors:  L Wallby; B Janerot-Sjöberg; T Steffensen; M Broqvist
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

9.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

Review 10.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.